Prostemics (KOSDAQ 203690, CEO Lee Won Jong) develops 'anti hair loss treatment spray using plasma anion technology' with a Japanese medical distributor. The company announced that it made a joint development contract for the 'hair loss treatment spray using plasma technology' with Metras on June 5.
| Website | http://www.prostemics.com |
| Revenue | $2 million |
| Employees | 6 (1 on RocketReach) |
| Address | 22 강남구 압구정로14길, Seoul 06029, KR |
| Phone | +82 2-545-2818 |
| Industry | Manufacturing General, Manufacturing |
| Keywords | Hair Loss Treatment, Anti Hair Loss, Plasma Technology, Hair Restoration, Hair Loss Prevention, Hair Care, Hair Follicle Treatment, Hair Health, Scalp Treatment, Joint Development |
| Competitors | Roche, Novartis, Bristol Myers Squibb, Amgen, Regeneron, Gilead Sciences, Receptos, a wholly-owned subsidiary of Celgene, Intellia Therapeutics, Inc., Editas Medicine, Cellectis +38 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 80 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular Prostemics employee's phone or email?
The Prostemics annual revenue was $2 million in 2026.
1 people are employed at Prostemics.
The NAICS codes for Prostemics are [325, 32, 3254].
The SIC codes for Prostemics are [28, 80, 283].